BIXT Message Board Post 27385346 | Bioxytran Inc
home / stock / bixt / bixt message board
steffanhen570
()
Posted on: Sep/11/2023 22:17:02
Hypoxia, a condition characterized by insufficient oxygen levels in the body, is just one of the medical challenges Bioxytran, Inc. is addressing. Their innovative approaches hold the potential to reshape how we treat a range of health conditions, from hypoxia-related ailments to other critical medical issues. For investors, Bioxytran, Inc. ($BIXT) represents more than just a financial opportunity. It's a chance to be part of a mission that can have a profound impact on healthcare. As they progress on their journey, investors may find not only potential returns but also the satisfaction of contributing to advancements in medical science.
News, Short Squeeze, Breakout and More Instantly...
-
BXT-25 is expected to oxygenate the brain BOSTON, MASSACHUSETTS, June 27, 2024 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing drugs to treat stroke and Alzheimer's disease, announced that Bioxtran’s...
-
X4 Pharmaceuticals Inc. (XFOR) is expected to report $-0.15 for Q4 2023 Li Ning Co., Ltd. ADR (LNNGY) is expected to report for Q4 2023 Xos Inc. (XOS) is expected to report $-2.4 for Q4 2023 PainReform Ltd. (PRFX) is expected to report for quarter end 2023-12-31 Muenchener Rueckve...
-
AIA Group Limited ADR (AAGIY) is expected to report for Q4 2023 Bank of Georgia Group Plc (BDGSF) is expected to report for quarter end 2023-12-31 SecureWorks Corp. (SCWX) is expected to report $-0.15 for Q4 2024 Acacia Research Corporation (ACTG) is expected to report for quarter end...